Matches in Wikidata for { <http://www.wikidata.org/entity/Q57911023> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- Q57911023 description "article scientifique publié en 2017" @default.
- Q57911023 description "im Mai 2017 veröffentlichter wissenschaftlicher Artikel" @default.
- Q57911023 description "wetenschappelijk artikel" @default.
- Q57911023 description "наукова стаття, опублікована в травні 2017" @default.
- Q57911023 name "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)" @default.
- Q57911023 name "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy" @default.
- Q57911023 type Item @default.
- Q57911023 label "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)" @default.
- Q57911023 label "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy" @default.
- Q57911023 prefLabel "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)" @default.
- Q57911023 prefLabel "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy" @default.
- Q57911023 P1433 Q57911023-BCD9C8D4-5B51-4311-B304-1E25930347B3 @default.
- Q57911023 P1476 Q57911023-28F0135A-E4C8-4E01-B825-F08E85F18D5D @default.
- Q57911023 P2093 Q57911023-0B4954A4-D452-4126-AE11-9391806C8359 @default.
- Q57911023 P2093 Q57911023-1779DA1D-0B09-4340-80DB-765AE0275BC0 @default.
- Q57911023 P2093 Q57911023-1DC7F699-3BCB-4A80-B6EB-979ACE500E14 @default.
- Q57911023 P2093 Q57911023-22F9EC38-CD21-47BF-82FE-27841E8C9549 @default.
- Q57911023 P2093 Q57911023-363FC28D-DDE1-4676-AABD-C80914AA3D73 @default.
- Q57911023 P2093 Q57911023-479C4397-CB06-4015-AFDA-30AB7191C40E @default.
- Q57911023 P2093 Q57911023-4A90A333-14C2-428C-B739-FB88F140AC91 @default.
- Q57911023 P2093 Q57911023-94B7B5D1-5855-4A7D-8FA2-0339E9209B89 @default.
- Q57911023 P2093 Q57911023-9E05F53C-1245-436E-B121-9FC55B1863EB @default.
- Q57911023 P2093 Q57911023-A01E6C8F-19A6-4CF2-B636-F57119C0AEFB @default.
- Q57911023 P2093 Q57911023-A1076E53-A0DF-4F73-A73C-CD195FA589F6 @default.
- Q57911023 P2093 Q57911023-A2562AD7-C0D5-4050-BB50-EEA6B481F3C0 @default.
- Q57911023 P2093 Q57911023-A56CE84C-4636-4F9E-8446-D227713B5A8D @default.
- Q57911023 P2093 Q57911023-ACB0EFEA-173F-4E2B-B600-C4F4C91541CD @default.
- Q57911023 P2093 Q57911023-BA0C873F-6303-4A09-A1BF-56B9CDBDE282 @default.
- Q57911023 P2093 Q57911023-CEA5037E-E67B-4E09-AA6B-A285BFFBB5B4 @default.
- Q57911023 P2093 Q57911023-D6DC0C62-745F-4479-96B5-6BF3ECC1A56B @default.
- Q57911023 P2093 Q57911023-F8F7AAC3-6608-4A3F-A398-49EFADC0995B @default.
- Q57911023 P304 Q57911023-7D6D6B21-6219-459A-B521-FCB571F731B3 @default.
- Q57911023 P31 Q57911023-16575C98-2709-43EE-BBBB-0F5A57CC2BCB @default.
- Q57911023 P356 Q57911023-FF8CF7EC-C19F-4EAC-91C5-38F5BB7D0D54 @default.
- Q57911023 P407 Q57911023-9020E54A-5EE8-4075-93D9-9E649D299D93 @default.
- Q57911023 P433 Q57911023-54D0980C-0142-4BA5-965B-83271B46511F @default.
- Q57911023 P478 Q57911023-D1CFD742-CE76-41FA-B150-036269E48B15 @default.
- Q57911023 P50 Q57911023-94173604-9367-4467-B517-03916CFB23FB @default.
- Q57911023 P50 Q57911023-D107E237-ED00-4C0D-A5F7-3BB1549B6901 @default.
- Q57911023 P577 Q57911023-7C6D73A0-1BE8-4F70-9BF1-D87745747763 @default.
- Q57911023 P921 Q57911023-C0656597-59DD-4437-ACD7-91217B8233A7 @default.
- Q57911023 P921 Q57911023-C6DA4DEE-1541-47E1-BDA2-07120383E596 @default.
- Q57911023 P356 JCO.2017.35.15_SUPPL.TPS4596 @default.
- Q57911023 P1433 Q400292 @default.
- Q57911023 P1476 "A phase III randomized study comparing perioperative nivolumab vs. observation in patients with localized renal cell carcinoma undergoing nephrectomy (PROSPER RCC)" @default.
- Q57911023 P2093 "Anil Kapoor" @default.
- Q57911023 P2093 "Brian M. Shuch" @default.
- Q57911023 P2093 "Daniel J. George" @default.
- Q57911023 P2093 "Daniel Yick Chin Heng" @default.
- Q57911023 P2093 "David Cella" @default.
- Q57911023 P2093 "David F. McDermott" @default.
- Q57911023 P2093 "Eliezer Mendel Van Allen" @default.
- Q57911023 P2093 "Lauren Christine Harshman" @default.
- Q57911023 P2093 "M Dror Michaelson" @default.
- Q57911023 P2093 "Maneka Puligandla" @default.
- Q57911023 P2093 "Michael A.S. Jewett" @default.
- Q57911023 P2093 "Michael Anthony Carducci" @default.
- Q57911023 P2093 "Mohamad Allaf" @default.
- Q57911023 P2093 "Naomi B. Haas" @default.
- Q57911023 P2093 "Primo Lara" @default.
- Q57911023 P2093 "Rajan T Gupta" @default.
- Q57911023 P2093 "Rupal Satish Bhatt" @default.
- Q57911023 P2093 "Toni K. Choueiri" @default.
- Q57911023 P304 "TPS4596-TPS4596" @default.
- Q57911023 P31 Q13442814 @default.
- Q57911023 P356 "10.1200/JCO.2017.35.15_SUPPL.TPS4596" @default.
- Q57911023 P407 Q1860 @default.
- Q57911023 P433 "15_suppl" @default.
- Q57911023 P478 "35" @default.
- Q57911023 P50 Q107723711 @default.
- Q57911023 P50 Q90424571 @default.
- Q57911023 P577 "2017-05-20T00:00:00Z" @default.
- Q57911023 P921 Q1164529 @default.
- Q57911023 P921 Q3421914 @default.